Overview NKG2D CAR-NK Cell Therapy in Patients With Refractory Metastatic Colorectal Cancer Status: Recruiting Trial end date: 2023-06-01 Target enrollment: Participant gender: Summary NKG2D CAR-NK Cell Therapy in Patients With Refractory Metastatic Colorectal Cancer Phase: Phase 1 Details Lead Sponsor: Zhejiang University